The medical community here is buzzing by retatrutide, a new dual GIP and GLP-1 target that’s showing significant results in clinical studies . This treatment works by imitating natural hormones to affect appetite and boost feelings of satiety, ultimately resulting in substantial body reduction . While currently under evaluation and not readily av